Cannabigerol

(CBG)

What is CBG?

Cannabigerol, or CBG, is a non-psychoactive cannabinoid typically most abundant in low-THC, high-CBD cannabis strains, including hemp. Like THC, CBG reacts with the cannabinoid receptors in the brain. CBG, however, acts as a buffer to the psychoactivity of THC, by working to alleviate the paranoia sometimes caused by higher levels of THC.

CBG works to fight inflammation, pain and nausea, and works to slow the proliferation of cancer cells. Research has shown it also significantly reduces intraocular eye pressure caused by glaucoma. Strains high in CBG will be beneficial treating conditions such as inflammatory bowel disease, Crohn’s disease and cancer.

Effects & Benefits

Research has shown that CBG is effective in the treatment of a variety of symptoms and conditions. Examples of conditions for which CBG is particularly effective in providing symptom relief are listed below:

  • Glaucoma
  • Cancer
  • Crohn’s disease
  • Irritable bowel syndrome

Research Studies

Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid.

A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis.

A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis.

Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease.

Related Conditions